biote Corp appoints Robert Peterson as CFO, succeeding Samar Kamdar

biote Corp.

Robert Peterson named CFO effective Jan 8, 2024; base salary $425,000 plus bonus and equity awards.
Samar Kamdar transitions out as CFO, to remain through Feb 29, 2024 as advisor; transition unrelated to financial results.
Peterson previously CFO of Virbac Corp; brings 15 years health/wellness and public company experience.
Peterson receives initial RSUs valued at $177,000 and 400,000 stock options under 2022 Equity Incentive Plan.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Samar Kamdar

Chief Financial Officer

BTMD · biote Corp.

Effective: 2024-01-08
Successor: Robert Peterson
Filed: January 11, 2024, 6:59 PM ET

Samar Kamdar, the Company’s current Chief Financial Officer, will transition out of his role, effective immediately.

Appointed

Robert Peterson

Chief Financial Officer

BTMD · biote Corp.

Effective: 2024-01-08
Filed: January 11, 2024, 6:59 PM ET

On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Samar Kamdar changed role as Chief Financial Officer at biote Corp..

Action: will transition out of his role
Role: Chief Financial Officer

Exact text from the filing

Samar Kamdar, the Company’s current Chief Financial Officer, will transition out of his role, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Peterson was appointed as Chief Financial Officer at biote Corp..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.

View on SEC.gov

biote Corp. filing history →

Source: SEC EDGAR

accession 0001193125-24-006634

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.